Adelaide, Australia

Andrew Jeremy Dunbar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gropep Pty, Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Jeremy Dunbar. Retrieved from https://idiyas.com/inventor/andrew-jeremy-dunbar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Jeremy Dunbar: Innovator in Biopharma

Introduction

Andrew Jeremy Dunbar is an accomplished inventor based in Adelaide, South Australia. He is currently associated with Novozymes Biopharma Australia Limited, where he contributes to advancements in the biopharmaceutical sector. Despite having no patents to his name, his work in the industry is noteworthy.

Latest Patents

As of now, Andrew Jeremy Dunbar holds 1 patents. This indicates that his contributions may be more focused on research and development rather than patentable inventions.

Career Highlights

Throughout his career, Andrew has been involved in various projects that aim to enhance biopharmaceutical processes. His expertise in the field has made him a valuable asset to his company and the industry at large.

Collaborations

Andrew collaborates closely with his coworker, Christopher Goddard. Together, they work on innovative solutions that address challenges in biopharma.

Conclusion

In summary, Andrew Jeremy Dunbar is a dedicated inventor in the biopharmaceutical field, contributing significantly to his company and the industry despite not holding any patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…